• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Respir Cell Mol Biol. Phosphatidylglycerol Suppresses Influenza A Virus Infection

Giuseppe

Emeritus
[Source: American Journal of Respiratory Cell and Molecular Biology, full text: (LINK). Abstract, edited.]


Am. J. Respir. Cell Mol. Biol. 2011, doi:10.1165/2011-0194OC
Submitted on June 10, 2011
Accepted on November 3, 2011



Phosphatidylglycerol Suppresses Influenza A Virus Infection


Mari Numata<SUP>1</SUP>, Pitchaimani Kandasamy<SUP>1</SUP>, Yoji Nagashima<SUP>2</SUP>, Janelle Posey<SUP>1</SUP>, Kevan Hartshorn<SUP>3</SUP>, David Woodland<SUP>4</SUP>, and Dennis R Voelker<SUP>1</SUP><SUP>*</SUP>

<SUP>1</SUP> Department of Medicine, Program in Cell Biology, National Jewish Health, Denver, Colorado, United States, <SUP>2</SUP> Department of Pathology, Yokohama City University School of Medicine, Yokohama, Japan, <SUP>3</SUP> Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States, <SUP>4</SUP> Trudeau Institute, Saranac, New York, United States
<SUP>*</SUP> To whom correspondence should be addressed. E-mail: voelkerd@NJHealth.org .


Influenza A virus (IAV) is a worldwide public health problem<SUP> </SUP>causing 500,000 deaths each year. Palmitoyl-oleoyl-phophatidylglycerol<SUP> </SUP>(POPG) is a minor component of pulmonary surfactant, which has<SUP> </SUP>recently been reported to exert potent regulatory functions<SUP> </SUP>upon the innate immune system. In this report we demonstrate<SUP> </SUP>that POPG acts as a strong anti-viral agent against IAV. POPG<SUP> </SUP>markedly attenuated IL-8 production and cell death induced by<SUP> </SUP>IAV in cultured human bronchial epithelial cells. The lipid<SUP> </SUP>also suppressed viral attachment to the plasma membrane and<SUP> </SUP>subsequent replication in MDCK cells. Two virus strains, H1N1-PR8-IAV<SUP> </SUP>and H3N2-IAV bind to POPG with high affinity but exhibit only<SUP> </SUP>low affinity interactions with the structurally related lipid<SUP> </SUP>palmitoyl-oleoyl-phosphatidylcholine. Intranasal inoculation<SUP> </SUP>of H1N1-PR8-IAV in mice, in the presence of POPG, markedly suppressed<SUP> </SUP>the development of inflammatory cell infiltrates and the induction<SUP> </SUP>of IFN-
ggr.gif
recovered in bronchoalveolar lavage, and viral titers<SUP> </SUP>recovered from the lungs after 5 days of infection. These findings<SUP> </SUP>identify supplementary POPG as a potentially important new approach<SUP> </SUP>for treatment of IAV infections.



<SUP></SUP>Key words: Antiviral ? Innate immunity ? Pulmonary surfactant
- ------
 
Back
Top Bottom